| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $195.5M | — | +1.4% |
| Cost of Revenue | $44.6M | — | +6.8% |
| Gross Profit | $150.8M | — | -0.0% |
| R&D Expense | $43.3M | — | -6.2% |
| SG&A Expense | $35.2M | — | +25.3% |
| Operating Income | $32.7M | — | -15.4% |
| Pre-tax Income | $37.7M | — | -16.2% |
| Income Tax | $6.2M | — | -14.1% |
| Net Income | $31.5M | — | -16.6% |
| EPS (Basic) | $0.25 | — | -10.7% |
| EPS (Diluted) | $0.24 | — | -11.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $328.4M | +11.6% | +7.9% |
| Short-term Investments | $251.3M | -33.6% | -20.9% |
| Accounts Receivable | $75.9M | -0.4% | -2.6% |
| Current Assets | $883.3M | -7.1% | -5.8% |
| Total Assets | $1.24B | -4.4% | +0.2% |
| Current Liabilities | $647.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $23.0M | — | -37.7% |
| Capital Expenditures | $1.7M | — | -30.3% |
| Investing Cash Flow | $118.2M | — | +2363.3% |
| Financing Cash Flow | -$84.3M | — | -541.0% |
| Free Cash Flow | $21.3M | — | -38.3% |
| +135.6% |
| Long-term Debt | $360.2M | +0.1% | +0.5% |
| Total Liabilities | $672.3M | +0.5% | +4.1% |
| Stockholders' Equity | $569.6M | -9.6% | -4.2% |